Applied DNA Sciences Inc (OTCMKTS:APDN) has been assigned a $5.00 price target by stock analysts at Maxim Group in a research report issued on Friday. The firm currently has a “buy” rating on the technology company’s stock. Maxim Group’s price objective indicates a potential upside of 189.02% from the company’s current price.

Separately, ValuEngine cut shares of Applied DNA Sciences from a “sell” rating to a “strong sell” rating in a research note on Friday, June 2nd.

Applied DNA Sciences (OTCMKTS:APDN) traded up 4.85% on Friday, hitting $1.73. 262,372 shares of the stock traded hands. The stock’s market cap is $47.36 million. Applied DNA Sciences has a 52 week low of $0.90 and a 52 week high of $3.47. The firm’s 50 day moving average is $1.68 and its 200 day moving average is $1.61.

Applied DNA Sciences (OTCMKTS:APDN) last announced its quarterly earnings results on Thursday, August 10th. The technology company reported ($0.10) EPS for the quarter, beating analysts’ consensus estimates of ($0.14) by $0.04. The firm had revenue of $1.80 million during the quarter, compared to analysts’ expectations of $2.18 million. Applied DNA Sciences had a negative net margin of 378.72% and a negative return on equity of 128.10%. The company’s revenue for the quarter was up 176.9% compared to the same quarter last year. During the same quarter last year, the company posted ($0.14) earnings per share. Equities analysts anticipate that Applied DNA Sciences will post ($0.39) earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: “Applied DNA Sciences Inc (APDN) Given a $5.00 Price Target by Maxim Group Analysts” was originally published by American Banking News and is the sole property of of American Banking News. If you are accessing this news story on another domain, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright law. The original version of this news story can be read at

About Applied DNA Sciences

Applied DNA Sciences, Inc is engaged in creating security solutions addressing the challenges of modern commerce. The Company is also engaged in the large-scale production of specific deoxyribonucleic acid (DNA) sequences using the polymerase chain reaction (PCR). Its principal technology platform includes SigNature DNA, SigNature T DNA, fiberTyping, DNAnet, digitalDNA, SigNify and Beacon.

Receive News & Ratings for Applied DNA Sciences Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied DNA Sciences Inc and related companies with's FREE daily email newsletter.